People · Operator
Named in public records as an officer, director or promoter · active 2012–2025 · Biotech / Pharma, Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Swift Biosciences, Inc. | — | Biotech / Pharma | Series A | $31.5M | $134.0M | 2012 |
| KromaTiD, Inc. | — | Other | Series A | $16.0M | $12.1M | 2021 |
| ViroCyt, LLC | — | Other Health Care | Series A | $14.3M | $70.0M | 2014 |
Walter Young at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Walter Young on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jack Ball | 3 | 10 |
| Nathan Wood | 2 | 3 |
| Mark Lewis | 1 | 15 |
| Dan Watkins | 1 | 8 |
| Robert Kline | 1 | 6 |
| Mark Lupa | 1 | 5 |
| Linda Tufts | 1 | 5 |
| Dan Kidle | 1 | 4 |
| Vic Myer | 1 | 3 |
| Terry Opgenorth | 1 | 3 |
| James Chomas | 1 | 3 |
| Jack Ball, Jr. | 1 | 2 |
| Kathy Rowlen | 1 | 2 |
| David Brunel | 1 | 2 |
| Dan Mitchell | 1 | 2 |
| Priyadarshini Gogoi | 1 | 2 |
| Peter Kleinhenz | 1 | 2 |
| Tim Harkins | 1 | 1 |
| Susan Bailey | 1 | 1 |
| David Olson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.